VIA
ROIV icon

Virtus Investment Advisers’s Roivant Sciences ROIV Stock Holding History

Virtus Investment Advisers’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.37M Buy
38,711
+509
+1% +$15K 0.32% 140
2026
Q1 		$1.06M Buy
38,202
+7,280
+24% +$187K 0.29% 137
2025
Q4 		$671K Sell
30,922
-7,822
-20% -$154K 0.18% 191
2025
Q3 		$586K Hold
38,744
– – 0.17% 190
2025
Q2 		$437K Buy
38,744
+8,525
+28% +$92.4K 0.15% 209
2025
Q1 		$305K Buy
+30,219
New +$327K 0.08% 241

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Virtus Investment Advisers's ROIV Position: Q2 2026 in Review

Virtus Investment Advisers increased its Roivant Sciences (ROIV) stake by 1.3% in Q2 2026, buying an estimated $15K and bringing the position to 38,711 shares worth $1.37M. The position accounts for 0.32% of the portfolio, ranked #140.

Virtus Investment Advisers first reported a position in ROIV in Q1 2025 and has held it in 6 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Virtus Investment Advisers held 38,711 shares of Roivant Sciences worth $1.37M as of Q2 2026.
  • Virtus Investment Advisers bought 509 Roivant Sciences shares in Q2 2026, an estimated $15K.
  • Roivant Sciences made up 0.32% of Virtus Investment Advisers's portfolio in Q2 2026, its #140 holding.
  • Virtus Investment Advisers first reported a position in Roivant Sciences in Q1 2025 and has held it in 6 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.